GM-CSF Autoantibody-positive Pulmonary Alveolar Proteinosis with Simultaneous Myeloproliferative Neoplasm

Intern Med. 2017;56(4):435-439. doi: 10.2169/internalmedicine.56.6920. Epub 2017 Feb 15.

Abstract

Pulmonary alveolar proteinosis (PAP) is classified as autoimmune, secondary, or genetic. We herein describe a 69-year-old man with autoimmune PAP, simultaneously diagnosed with myeloproliferative neoplasm (MPN). Two years after the diagnosis, the MPN progressed to acute myeloid leukemia, and the patient died from an alveolar hemorrhage during remission induction chemotherapy. Throughout the clinical course, no progression of PAP was observed, despite the progression to leukemia. There are few reports of autoimmune PAP with hematological malignancy, and this case demonstrated that an evaluation for GM-CSF autoantibodies is important for distinguishing the autoimmune and secondary forms of PAP, even if the patient has hematological malignancy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Autoantibodies / blood*
  • Autoimmune Diseases / complications
  • Autoimmune Diseases / diagnosis*
  • Autoimmune Diseases / pathology
  • Biopsy
  • Disease Progression
  • Fatal Outcome
  • Granulocyte-Macrophage Colony-Stimulating Factor / immunology*
  • Humans
  • Leukemia, Myeloid, Acute / etiology
  • Lung / pathology
  • Male
  • Myeloproliferative Disorders / etiology*
  • Pulmonary Alveolar Proteinosis / complications
  • Pulmonary Alveolar Proteinosis / diagnosis*
  • Pulmonary Alveolar Proteinosis / pathology
  • Radiography, Thoracic
  • Tomography, X-Ray Computed

Substances

  • Autoantibodies
  • Granulocyte-Macrophage Colony-Stimulating Factor